PharMerica Corp. Company Profile (NYSE:PMC)

About PharMerica Corp.

PharMerica Corp. logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Stores
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: PMC
  • CUSIP: 71714F10
Key Metrics:
  • Previous Close: $27.66
  • 50 Day Moving Average: $27.22
  • 200 Day Moving Average: $25.52
  • 52-Week Range: $19.79 - $35.81
  • Trailing P/E Ratio: 28.57
  • Foreward P/E Ratio: 12.24
  • P/E Growth: 1.98
  • Market Cap: $850.93M
  • Outstanding Shares: 30,764,000
  • Beta: 0.88
  • Net Margins: 1.44%
  • Return on Equity: 10.00%
  • Return on Assets: 4.51%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 2.93%
  • Quick Ratio: 1.98%
Additional Links:
Companies Related to PharMerica Corp.:

Analyst Ratings

Consensus Ratings for PharMerica Corp. (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $31.83 (15.09% upside)

Analysts' Ratings History for PharMerica Corp. (NYSE:PMC)
DateFirmActionRatingPrice TargetDetails
6/7/2016Bank of America Corp.Initiated CoverageBuy$32.00View Rating Details
5/10/2016Barrington ResearchReiterated RatingOutperform$30.00 -> $34.00View Rating Details
3/15/2016Credit Suisse Group AGInitiated CoverageOutperform$30.00View Rating Details
2/29/2016KeyCorpLower Price TargetOverweight$39.00 -> $32.00View Rating Details
2/29/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $22.00View Rating Details
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for PharMerica Corp. (NYSE:PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016ListenView Earnings Details
8/9/2016Q216$0.47$0.47$508.31 million$519.60 millionViewListenView Earnings Details
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details
8/2/2012$0.30$0.32ViewN/AView Earnings Details
5/2/2012$0.27$0.30ViewN/AView Earnings Details
2/9/2012$0.21$0.27ViewN/AView Earnings Details
11/3/2011$0.20$0.31ViewN/AView Earnings Details
8/4/2011$0.20$0.32ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/24/2011$0.17$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for PharMerica Corp. (NYSE:PMC)
Current Year EPS Consensus Estimate: $2.01 EPS
Next Year EPS Consensus Estimate: $2.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.36$0.48$0.41
Q2 20162$0.37$0.46$0.42
Q3 20162$0.49$0.50$0.50
Q4 20162$0.54$0.54$0.54
Q1 20171$0.51$0.51$0.51
Q2 20171$0.55$0.55$0.55
Q3 20171$0.58$0.58$0.58
Q4 20171$0.61$0.61$0.61
(Data provided by Zacks Investment Research)


Dividend History for PharMerica Corp. (NYSE:PMC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for PharMerica Corp. (NYSE:PMC)
Insider Ownership Percentage: 5.04%
Institutional Ownership Percentage: 92.27%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for PharMerica Corp. (NYSE:PMC)
DateHeadline logoYearly EPS Estimate Of Pharmerica Corporation (NYSE:PMC) At $2.09 - Stocks Daily (NYSE:PMC) - October 22 at 6:18 PM
News IconPharMerica Corp. (PMC) Position Lowered by Strs Ohio - DailyQuint (NYSE:PMC) - October 20 at 7:05 PM
News IconPharmerica Corporation (NYSE:PMC) Updated Broker Price Targets - The De Soto Edge (NYSE:PMC) - October 19 at 3:22 PM logoPharmerica Corporation (NYSE:PMC) Is Expected To Post EPS Of $0.56 - (NYSE:PMC) - October 19 at 3:22 PM
News IconPharMerica Announces Third Quarter 2016 Earnings Call And Webcast (NYSE:PMC) - October 17 at 6:43 PM
News IconStock Watch Near-Term: Pharmerica Corporation (NYSE:PMC) - Recall News (NYSE:PMC) - October 17 at 11:57 AM
News IconBNP Paribas Arbitrage SA Reduces Position in PharMerica Corp. (PMC) - DailyQuint (NYSE:PMC) - October 14 at 6:34 PM logoPharMerica Corporation Announces Third Quarter 2016 Earnings Call and Webcast (NYSE:PMC) - October 14 at 6:34 PM
News IconStock Perspective: Pharmerica Corporation (NYSE:PMC) Earnings in View - CSZ News (NYSE:PMC) - October 13 at 10:28 AM logoPeloton Approved for U.S. OTC QB Market Listing (NYSE:PMC) - October 10 at 6:22 PM
News IconLatest Analyst Ratings For Pharmerica Corporation (NYSE:PMC) - The De Soto Edge (NYSE:PMC) - October 9 at 6:06 PM
News IconPharmerica Corporation (NYSE:PMC) Updated Analyst Coverage - NewsDen (NYSE:PMC) - October 8 at 11:15 AM logoPharMerica: M&A Process Likely To Fail Causing Stock To Crack (NYSE:PMC) - October 6 at 6:36 PM
News IconAnalysts Implying Upside & Long Term Growth for PharMerica Corporation (NYSE:PMC) - CSZ News (NYSE:PMC) - October 6 at 12:21 PM logoPharMerica: M&A Process Likely To Fail Causing Stock To Crack - Seeking Alpha (NYSE:PMC) - October 5 at 12:02 PM
News IconBrokerage Firm Target Update on Pharmerica Corporation (NYSE:PMC) - Recall News (NYSE:PMC) - October 4 at 6:23 PM logoPeloton Commences Drilling at Golden Trail Project and Surface Mapping and Geochemistry at Independence Valley Project, Elko County, Nevada (NYSE:PMC) - October 4 at 11:32 AM logoPeloton Added to the CSE Composite Index (NYSE:PMC) - September 26 at 11:39 AM logoPeloton Applies to List on U.S. OTC QB Market as well as Canada (NYSE:PMC) - September 16 at 6:35 PM logo5 Health Care Stocks John Paulson Is Betting On in 2016 (NYSE:PMC) - September 10 at 11:01 AM logoWhat can Pharmerica do to get buyers to swipe right? (NYSE:PMC) - August 30 at 6:46 PM logoPharMerica Corp.: Strong price momentum but will it sustain? (NYSE:PMC) - August 25 at 6:59 PM logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 25, 2016 (NYSE:PMC) - August 25 at 11:58 AM logoWhy PharMerica Soared 13.4% Today (NYSE:PMC) - August 24 at 9:16 PM logoPharMerica Rises 14.24% on Heavy Volume: Watch For Potential Pullback (NYSE:PMC) - August 24 at 6:37 PM
News IconPharMerica Exploring Strategic Alternatives, Including Sale -Reuters (NYSE:PMC) - August 24 at 6:37 PM logoMid-Afternoon Market Update: Crude Oil Down 2.8%; PharMerica Shares Spike Higher (NYSE:PMC) - August 24 at 3:45 PM logoUPDATE 1-Pharmacy manager PharMerica explores possible sale -sources (NYSE:PMC) - August 24 at 1:20 PM logoSpecialty pharmacy PharMerica explores possible sale: sources (NYSE:PMC) - August 24 at 11:27 AM logoSpecialty pharmacy PharMerica explores possible sale -sources (NYSE:PMC) - August 24 at 11:27 AM
News IconClearspring seeks to sell Medical Pharmacies, could fetch $1 bln: Reuters (NYSE:PMC) - August 23 at 6:58 PM logoETF’s with exposure to PharMerica Corp. : August 23, 2016 (NYSE:PMC) - August 23 at 6:58 PM logoPHARMERICA CORP Financials (NYSE:PMC) - August 18 at 7:01 PM
News IconPharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need for Effective, Focused Advocacy on Long Term Care (LTC) Pharmacy Issues (NYSE:PMC) - August 16 at 6:59 PM logoPeloton Acquires Independence Valley Project, Elko County, Nevada (NYSE:PMC) - August 16 at 6:59 PM logoPharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NYSE:PMC) - August 12 at 6:59 PM logoETF’s with exposure to PharMerica Corp. : August 11, 2016 (NYSE:PMC) - August 11 at 7:22 PM logoPHARMERICA CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal (NYSE:PMC) - August 10 at 7:19 PM logoPharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : August 10, 2016 (NYSE:PMC) - August 10 at 9:58 AM logoPharMerica's (PMC) CEO Greg Weishar on Q2 2016 Results - Earnings Call Transcript (NYSE:PMC) - August 9 at 7:08 PM logoOne of Pharmerica's top execs plans to retire (NYSE:PMC) - August 9 at 7:08 PM logoPharMerica Corporation: PharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr. (NYSE:PMC) - August 9 at 10:03 AM logoPharMerica meets 2Q profit forecasts (NYSE:PMC) - August 9 at 10:03 AM logoPharMerica Reports Second Quarter 2016 Results (NYSE:PMC) - August 9 at 10:03 AM logoPharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr. (NYSE:PMC) - August 9 at 10:03 AM logoThe Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways (NYSE:PMC) - August 9 at 10:03 AM logoPharMerica Corp Earnings Call scheduled for 10:00 am ET today (NYSE:PMC) - August 9 at 10:03 AM logoPeloton Completes Private Placement Financing (NYSE:PMC) - August 6 at 9:40 AM logoPeloton Completes Airborne Hyperspectral Imaging Survey Over Golden Trial Project, Nevada (NYSE:PMC) - July 28 at 11:28 AM logoPharMerica Corp. – Value Analysis (NYSE:PMC) : July 18, 2016 (NYSE:PMC) - July 18 at 4:10 PM


PharMerica Corp. (NYSE:PMC) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by Staff